Health After Covid-19 in Tyrol
Health After COVID-19 in the European Region Tyrol - South Tyrol
1 other identifier
observational
1,000
1 country
1
Brief Summary
The aim of the regional online questionnaire is to better understand the pattern of acute infection and the time of recovery of various symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2020
CompletedStudy Start
First participant enrolled
September 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedDecember 10, 2020
September 1, 2020
1 year
September 29, 2020
December 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Population based data on spectrum and recovery from COVID-19 symptoms
Percentage of patients manifesting ongoing symptoms after 2 weeks of infection.
two weeks after infection
Population based data on spectrum and recovery from COVID-19 symptoms
Spectrum of symptoms at onset and at end of disease.
up to 24 weeks
Predictors of recovery.
Identification of symptoms or comorbidities associated with Long-Covid-19.
up to 24 weeks
Interventions
We invite volunteers after COVID-19 to participate in an online survey.
Eligibility Criteria
voluntary participation of probands after COVID-19, resident in Tyrol, Austria, with access to online survey;
You may qualify if:
- status post COVID-19 infection, defined by a positive SARS-Cov-2 PCR or antibody test
- age ≥ 16years
- resident in Tyrol (Austria)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University Innsbrucklead
- Claudiana Landesfachhochschulecollaborator
Study Sites (1)
Medizinische Universität Innsbruck
Innsbruck, Tyrol, 6020, Austria
Related Publications (2)
Rass V, Tymoszuk P, Sahanic S, Heim B, Ausserhofer D, Lindner A, Kofler M, Mahlknecht P, Boehm A, Hufner K, Pizzini A, Sonnweber T, Kurz K, Pfeifer B, Kiechl S, Peball M, Kindl P, Putnina L, Fava E, Djamshidian A, Huber A, Wiedermann CJ, Sperner-Unterweger B, Woll E, Beer R, Schiefecker AJ, Bellmann-Weiler R, Bachler H, Tancevski I, Pfausler B, Piccoliori G, Seppi K, Weiss G, Loffler-Ragg J, Helbok R. Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae. Eur Arch Otorhinolaryngol. 2023 Nov;280(11):5115-5128. doi: 10.1007/s00405-023-08163-x. Epub 2023 Sep 5.
PMID: 37670171DERIVEDHufner K, Tymoszuk P, Ausserhofer D, Sahanic S, Pizzini A, Rass V, Galffy M, Bohm A, Kurz K, Sonnweber T, Tancevski I, Kiechl S, Huber A, Plagg B, Wiedermann CJ, Bellmann-Weiler R, Bachler H, Weiss G, Piccoliori G, Helbok R, Loeffler-Ragg J, Sperner-Unterweger B. Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management? Front Med (Lausanne). 2022 Mar 14;9:792881. doi: 10.3389/fmed.2022.792881. eCollection 2022.
PMID: 35360744DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2020
First Posted
December 10, 2020
Study Start
September 30, 2020
Primary Completion
September 30, 2021
Study Completion
December 31, 2021
Last Updated
December 10, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share